IRIS UniCatt

Basile, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.555
AS - Asia 2.873
EU - Europa 2.172
SA - Sud America 523
AF - Africa 75
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.432
SG - Singapore 1.391
CN - Cina 618
SE - Svezia 520
BR - Brasile 438
IT - Italia 378
VN - Vietnam 293
DE - Germania 283
FR - Francia 235
PL - Polonia 137
GB - Regno Unito 134
IE - Irlanda 126
IN - India 118
FI - Finlandia 89
JP - Giappone 89
ID - Indonesia 81
RU - Federazione Russa 66
CA - Canada 55
HK - Hong Kong 55
MX - Messico 48
BD - Bangladesh 44
UA - Ucraina 36
TR - Turchia 34
NL - Olanda 29
AR - Argentina 28
KR - Corea 28
ZA - Sudafrica 25
ES - Italia 23
BE - Belgio 22
IQ - Iraq 20
AT - Austria 14
CZ - Repubblica Ceca 13
MA - Marocco 13
SA - Arabia Saudita 13
CO - Colombia 10
JO - Giordania 10
LT - Lituania 10
AU - Australia 9
CL - Cile 9
EC - Ecuador 9
IR - Iran 9
TN - Tunisia 9
VE - Venezuela 9
CI - Costa d'Avorio 8
NZ - Nuova Zelanda 8
PE - Perù 8
PT - Portogallo 8
KE - Kenya 7
MY - Malesia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
BY - Bielorussia 6
DK - Danimarca 6
DZ - Algeria 6
GR - Grecia 6
JM - Giamaica 6
LB - Libano 6
PK - Pakistan 6
PY - Paraguay 6
CH - Svizzera 5
KZ - Kazakistan 4
PH - Filippine 4
RO - Romania 4
AL - Albania 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
LV - Lettonia 3
MM - Myanmar 3
OM - Oman 3
AZ - Azerbaigian 2
BO - Bolivia 2
CG - Congo 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
EU - Europa 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
Totale 9.208
Salva come PNG Salva come JPEG
Città #
Singapore 832
Chandler 492
Ashburn 408
San Jose 319
New York 164
Beijing 132
Dublin 125
Warsaw 123
The Dalles 97
Los Angeles 96
Ho Chi Minh City 95
Dallas 93
Rome 86
Tokyo 86
Hefei 77
Council Bluffs 76
Lauterbourg 74
Jakarta 73
Frankfurt am Main 72
Hanoi 64
San Mateo 62
Helsinki 61
Boston 53
Fairfield 52
Munich 51
São Paulo 50
Hong Kong 48
North Bergen 47
Wilmington 46
Milan 43
Marseille 42
Princeton 42
Moscow 39
Houston 37
Orem 34
Ann Arbor 30
Nanjing 30
Seattle 30
Jacksonville 29
Cattolica 28
Boardman 27
London 27
Hyderabad 24
Seoul 24
Chicago 23
Da Nang 23
Paris 23
Santa Clara 23
Atlanta 22
Kent 22
Woodbridge 22
Bremen 21
Dearborn 21
Nuremberg 21
Chennai 20
Redwood City 20
Montreal 19
Brooklyn 18
Johannesburg 18
Mexico City 18
Poplar 18
Brussels 17
Stockholm 17
Denver 16
Toronto 16
Amsterdam 15
Rio de Janeiro 15
Bologna 14
Buffalo 14
Castelnuovo di Val di Cecina 14
Falls Church 14
Phoenix 14
San Francisco 13
Tianjin 13
Guangzhou 12
Haiphong 12
Hebei 12
Norwalk 12
Lappeenranta 11
Querétaro 11
Shenyang 11
Bexley 10
Edinburgh 10
Falkenstein 10
Lancaster 10
Manchester 10
Turku 10
Baghdad 9
Cambridge 9
Nanchang 9
Roubaix 9
Shanghai 9
Abidjan 8
Amman 8
Belo Horizonte 8
Brno 8
Curitiba 8
Düsseldorf 8
Izmir 8
Leawood 8
Totale 5.334
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 339
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 169
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 169
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 168
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 164
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 163
Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport 157
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 156
Evaluation of screening method for Bence Jones protein analysis 155
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 152
Immunological role of IgG subclasses 150
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 145
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 141
Overview of immune abnormalities in lysosomal storage disorders 141
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 140
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 140
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 139
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 138
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 134
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 133
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 132
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 132
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 130
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 130
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 129
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 127
Immunological role of IgG subclasses 127
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 126
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 125
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 124
Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection 124
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 123
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 123
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 122
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 121
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity 119
The Laboratory Role in anti-TNF Biological Therapy Era 118
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 118
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 118
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 116
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 116
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 116
Antenna-enhanced mid-infrared detection of extracellular vesicles derived from human cancer cell cultures 115
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 115
SARS-CoV-2 was already circulating in Italy, in early December 2019 113
Sensing red blood cell nano-mechanics: Toward a novel blood biomarker for Alzheimer’s disease 112
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 111
Heavy chain disease: Our experience 110
Serum free light chain quantitative assays: Dilemma of a biomarker 109
Anti-nuclear antibody detection in cryoprecipitates: Distinctive patterns in hepatitis C virus-infected patients 108
IgG cryoglobulinemia 105
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 103
Cryoglobulins: putative effectors of adaptive immune response 101
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 101
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 100
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 99
COVID-19, adaptative immune response and metabolic-associated liver disease 99
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 98
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 95
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 95
The dark side of current analytic methods for Bence Jones Proteinuria 95
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 92
Free light chains and autoimmunity 88
Type 2 cytokines and scleroderma interstitial lung disease 87
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 87
Calprotectin: two sides of the same coin 80
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis 80
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 78
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 76
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 74
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 72
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 72
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 71
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 67
SCREENING FOR THE IDENTIFICATION OF AUTOIMMUNE OR LYMPHOPROLIFERATIVE ONSET IN PATIENTS NAiVE TO HCV ANTIVIRAL TREATMENT 58
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 57
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 48
Post-pandemic drug and alcohol-related road accidents analysis in Central Italy area 34
Totale 9.395
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.747
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 17 70 42
2021/2022492 23 11 5 72 38 18 12 76 24 22 80 111
2022/20231.395 204 179 90 212 89 151 84 121 148 20 73 24
2023/2024839 35 194 12 85 26 161 67 34 6 43 72 104
2024/20251.729 60 50 118 84 154 95 40 97 248 156 360 267
2025/20264.104 547 121 309 587 818 213 798 206 265 240 0 0
Totale 9.395